Back to Journals » Infection and Drug Resistance » Volume 13

Inappropriate Antibiotic Use Among Inpatients Attending Madda Walabu University Goba Referral Hospital, Southeast Ethiopia: Implication for Future Use

Authors Mama M, Mamo A, Usman H, Hussen B, Hussen A, Morka G

Received 24 February 2020

Accepted for publication 23 April 2020

Published 12 May 2020 Volume 2020:13 Pages 1403—1409

DOI https://doi.org/10.2147/IDR.S251151

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Suresh Antony

Download Article [PDF] 

Mohammedaman Mama, Ayele Mamo, Heyder Usman, Bedru Hussen, Abduljewad Hussen, Geroma Morka

Department of Medical Laboratory Sciences, School of Medicine, Madda Walabu University Goba Referral Hospital, Bale-Goba, Ethiopia

Correspondence: Mohammedaman Mama Tel +251 912686689
Email [email protected]

Background: Ethiopia is one of the countries where the healthcare system is not yet developed to the required level; hence, it is not uncommon that drugs, particularly antimicrobials, are inappropriately used for infections by any causative agents, with or without prescription, in combination or not, and, of more concern, without sensitivity tests. So, it was considered important to assess the magnitude of inappropriate antimicrobial use among inpatients attending Madda Walabu University Goba Referral Hospital, southeast Ethiopia.
Methods: A health institution-based cross-sectional study was conducted from September 2018 to April 2019. Patient folders from collaborating wards were reviewed for antibiotic use. Inappropriateness of a drug or its dosage, or both, was considered in reference to the Ethiopian national treatment guideline. The information obtained was analyzed using SPSS version 20. Patterns of prescription of antimicrobials for the hospitalized patients were analyzed using simple descriptive statistics.
Results: A total of 801 antibiotics were written as prescriptions to 471 clients, 228 (47.6%) of whom had received two or more antibiotics at the time of the study. Of the total prescribed antibiotics, 142 (30.1%) had an inappropriate prescription. Genitourinary tract infections accounted for 42 (30.4%) of the inappropriate prescriptions due to the wrong dose and drugs. Cephalosporins were the most extensively prescribed class of antibiotics, 24.4% of which were inappropriately prescribed. Intravenous formulations made up the largest proportion of prescriptions, at 335 (41.8%). The most commonly prescribed antimicrobials were cephalosporins, 178 (38%); nitroimidazoles, 115 (24.5%); and macrolides, 53 (11.3%), while ceftriaxone was prescribed in 249 (53%) and metronidazole in 123 (26.2%) cases.
Conclusion: Low dose, inadequate duration and empiric use of antibiotics were major causes of inappropriate use in the study area. Therefore, local antimicrobial sensitivity tests, antibiotic stewardship and following the national treatment guideline are recommended to overcome inappropriate antimicrobial use.

Keywords: antibiotic use, appropriateness, Goba Referral Hospital

Introduction

Antibiotics are substances existing in nature or fully or partially synthesized in a factory, which are used to kill or check the growth of microorganisms that cause infectious diseases.1,2 Their development has been the most important advance in the prevention, control and cure of serious infections.3,4 Nevertheless, the widespread and haphazard use of these drugs,5,6 on top of poor practices related to disease prevention and control, has led to the development of resistance by many strains of microorganisms in many countries.7 This can cause infections that are not easy to treat, which require costly drugs and longer hospital stays, and cause increased rates of illness and death.810

According to the latest reports, it is estimated that as many as 10 million excess deaths will result from antimicrobial resistance in the next 30 years, and worldwide economic productivity could be negatively impacted by as much as 100 trillion USD if applicable efforts are not put in place to contain this menace.1113 The rate at which resistant strains are developing today is far greater than the rate at which new drugs are being discovered to combat the challenge,14 and this is the ultimate universal health issue of our time.15

Continuous evaluation of antimicrobial use is a useful strategy, as recommended by the WHO, for improving antibiotic use among patients to ensure the ongoing efficacy of antimicrobials and to control resistance and limit any detrimental effects on patients.2,5 In Ethiopia, as in many other developing countries where health-care systems are not yet adequately formed to address health problems, antibiotics are used more frequently than any other drugs for both bacterial and non-bacterial infections and are often bought without prescription,16 which is further compounded by empirical prescription without sensitivity testing.17,18 Therefore, precise evidence on the pattern of antimicrobial use is vital to respond to the problem of antimicrobial overuse and potential resistance. Hence, the intention of this research is to define the magnitude of inappropriate use of antibiotics among inpatients attending Madda Walabu University Goba Referral Hospital (MWUGRH).

Materials and Methods

Study Design, Area and Period

A facility-based cross-sectional study was conducted at MWUGRH, which is situated 445 km from Addis Ababa, the capital city of Ethiopia, in the southeast part of the country, from September 2018 to April 2019. The hospital is a teaching hospital located in Goba town and is the only referral hospital for the southeast part of the country.

Sample Size Determination and Sampling Technique

A formula was used to determine the sample size required for estimating the relevant proportion of a single population. Taking 70% inappropriate antibiotic use (P=0.7), 95% confidence interval (z=1.96) and 4% marginal error, the sample size was

After excluding 33 patients who had cards with incomplete information, the final sample size was 471. Patient cards were carefully chosen using a simple random sampling method within each ward and the cards were allocated proportionally to each ward (medical, surgical and gynecology/obstetric). All inpatient cards with an antibiotic prescription during the specified period were included, while incomplete patient cards, and cards for drugs other than antibiotics (antituberculosis, antifungal and antiviral agents) were excluded.

Data Abstraction Format

The format for data collection was based on WHO criteria19,20 and American Society of Health System Pharmacists guidelines.21 The tool for antibiotic use, in terms of the name of the antimicrobial prescribed and dosage regimen (dosage form, dose, route, frequency and duration of administration), was validated using the Ethiopian standard treatment guideline of 2010 for general hospitals; and the use of antibiotic combinations was noted. Sociodemographic characteristics and drug-related information, as mentioned above, were extracted from the records and entered on the data collection forms.

Appropriateness of Antibiotics

Antibiotic choice, dosage form, dose, frequency and duration were compared against the Ethiopian national treatment guideline to check antibiotic appropriateness. There is no ingrained formal guideline on antibiotic use in the hospital and use of the national guideline is not evident either. Furthermore, there is no established committee, such as a drugs and therapeutic committee or antibiotic stewardship committee, to safeguard antibiotic use in the hospital. This is further complicated by the absence of antibiotic susceptibility testing to check local resistance patterns.

Data Quality

One week before data collection, 5% of patient cards were examined as a pretest. The data collection format was translated into the local language (Afan Oromo) and back-translated to English to make sure that the consistency of the questionnaire was maintained. The entire data collection tool was checked for possible errors and corrections were made as required. A suitable person (an experienced pharmacist) was engaged for patient card review.

Data Analysis

Descriptive statistics were used to fix the means and extents for the prevalence study. In addition, data entry and analysis were accomplished using SPSS version 20, and then the entered data were edited, cleaned and analyzed.

Results

Sociodemographic Characteristics

A total of 471 inpatient folders were reviewed, of which the medical ward accounted for 177 (37.6%, 95% CI 33.1–41.6, followed by the surgical ward with 154 (32.7%, 95% CI 28.9–36.9) and the gynecology ward with 140 (29.7%, 95% CI 25.9–33.8). Among the included patients, the majority were female, accounting for 288 (61.1%, 95% CI 56.7–65.6). The age ranged from 15 to 90 years, with a median age of 27 years.

Prevalence of Antibiotic Use

Overall, 801 antibiotics were prescribed for 471 inpatients, of whom 228 (48.4%) received at least two during the study period. Most were intravenous antiobiotics, at 356 (76.4%, 95% CI 72.4–80), while only two patients received intramuscular antibiotics. One-hundred and ninety-four patients (41.2%, 95% CI 36.7–45.7) were on one antibiotic while the majority were on combination therapy, 277 (58.8%). The median number of antibiotics for each patient was two.

Indications for Antibiotic Use

Overall, 335 (71.1%, 95% CI 66.9–75.2) of 471 prescriptions were administered for therapy while 136 (28.9%, 95% CI 24.8–33.1) were for prophylaxis. As indicated in Table 1, cephalosporins were the most prescribed class of antibiotics (35.7%), with ceftriaxone accounting for all of this class (100%), followed by nitroimidazoles (22.3%), penicillins (11.04%) and glycopeptides (10.6%). When individual antibiotics were analyzed, ceftriaxone (47.6%) was the most prescribed, followed by metronidazole (28%) and vancomycin (10.6%). According to this study, genitourinary infection was the most commonly prescribed type of disease, accounting for 138 (29.3%), followed by skin and soft tissue infection, 87 (18.5%), and preoperative prophylaxis, 81 (17.2%) (Table 2).

Table 1 List of Antibiotics Prescribed to Hospitalized Patients Attending Madda Walabu University Goba Referral Hospital, Bale-Goba, from September 2018 to April 2019

Table 2 Indications for Antibiotic Use Among Patients Attending Madda Walabu University Goba Referral Hospital, Bale-Goba, from September 2018 to April 2019

Relevance of Antibiotic Use

With respect to the relevance of the antibiotic use, dosage and type of drug were checked, revealing that 329 patients (70%) had been prescribed an appropriate drug and dosage (dose, frequency and duration), while 142 (30.0%) were inappropriate because of the wrong drug, 56 (12%), or dosage form, 86 (18%), or both drug and dosage form. Cephalosporins and nitroimidazoles accounted for the highest level of inappropriate prescription (51.1%). Twenty-six patients (39.4%) with respiratory tract infections received inappropriate antibiotics, while patients with preoperative prophylaxis had the lowest level of inappropriate prescription (17.3%) (Tables 3 and 4).

Table 3 Appropriateness of Antibiotic Use Among Patients Attending Madda Walabu University Goba Referral Hospital, Bale-Goba, from September 2018 to April 2019

Table 4 Indication and Appropriateness of Antibiotic Use Among Patients Attending Madda Walabu University Goba Referral Hospital, Bale-Goba, from September 2018 to April 2019

Discussion

The proper use of antibiotics will have a positive impact on reducing antimicrobial resistance development, morbidity and mortality, and improving the cost of healthcare. This study identified that the majority of participants received antibiotics. The majority of antibiotics were prescribed for infections (71.1%) and surgical prophylaxis (28.9%). In this study, 70% of patients received appropriate antibiotics. This result is is higher than the levels of 59.9% and 53% found in studies carried out in healthcare facilities in Ghana22,23 and 49.9% in the USA,24 while it is comparable to findings of 64.6% and 67.4% of proper antibiotic use in studies conducted in Benin and Vietnam.5,25 It is different from the results of studies in Europe (30.1–35%)26,27 and lower than a study in Ethiopia (81.5%).28

High consumption of antibiotics is directly related to incorrect use of antibiotics, increased drug resistance and nosocomial infections.29,30 Studies conducted in Vietnam and Turkey showed 30.8% and 46.7% of inappropriate prescription,5,31 which is similar to the results of this study. Antibiotic use in the present study is much lower than in a study conducted in Pakistan, indicating 70% inappropriate use.32

In this study, the highest antibiotic use was seen in medical wards (38.6%) and the lowest in gynecology/obstetric wards (29.2%). This may be due to the high use of medical prophylaxis among medical patients. The majority of patients (47.1%) received two antibiotics, which is comparable with the study conducted in Ghana (42.6%).23 The majority of antibiotics were administered via the intravenous route (74.9%), which increases the risk of unsafe needle use.33

Regarding the number of antibiotics used, the study conducted in Ghana showed that metronidazole, ampicillin/amoxicillin, gentamicin and cloxacillin were used commonly,4,23 while ceftriaxone, metronidazole and azithromycin accounted for more than 50% of prescriptions in this study. These may be due to high usage during surgical prophylaxis and infection management. The use of carbapenems and glycopeptides in the participating wards in the hospital was low. This may reflect the high cost of purchasing these antibiotics. We have to use these antibiotics carefully in order to minimize the development of carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, which are associated with poor clinical outcomes.34

Of all prescriptions, 40% were for treating infections, of which the majority were treated with ceftriaxone (53%). This is an indication of the number one usage of ceftriaxone as a first line agent for infections and the high prevalence of ceftriaxone-resistant isolates in the current hospital, which was indicated in another study (Mama M, Usman H, Hussen B, Mamo A. Bacterial profile and resistance pattern among patients attending Madda Walabu University Goba Referral Hospital, Southeast Ethiopia; Unpublished; 2020). In this study, ceftriaxone and metronidazole were commonly used for surgical prophylaxis, which is a common practice for patients undergoing caesarean section.35 The high usage of metronidazole in the current study may aggravate healthcare-associated infections such as vancomycin-resistant Enterococcus infections.36,37

Limitations of the Study

The findings of this study cannot be generalized because it was conducted in a single hospital setting; in particular, these inpatients do not replicate the outpatient prescribing patterns.

Conclusion

In this study, a high prevalence of antibiotic use was identified, with high consumption by medical patients. Of all antibiotics, ceftriaxone and metronidazole were the most prescribed. There is inappropriate antibiotic use due to the wrong dose (low), duration, frequency and medications, which could be reduced by creating awareness in health professionals, developing and using institutional prescription guidelines, introducing local antibiotic sensitivity tests and establishing antibiotic stewardship committees.

Abbreviations

CI, confidence interval; MWUGRH, Madda Walabu University Goba Referral Hospital; USD, United States dollar; WHO, World Health Organization.

Data Sharing Statement

The datasets used in this study can be obtained from the corresponding author upon sensible application.

Ethics Approval

Ethical clearance was secured from the ethical review board of Madda Walabu University Goba Referral Hospital. A supporting letter was written to the hospital’s Medical Director. Since this is a document review, no patient consent was needed. Anonymity was maintained during report writing.

Acknowledgments

The authors would like to extend heartfelt thanks to Madda Walabu University for funding. The authors extend their appreciation to the data collectors.

Author Contributions

All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; gave final approval of the version to be published; and agree to be accountable for all aspects of the work.

Funding

Funding obtained from Madda Walabu University was used for data collection and interpretation only.

Disclosure

The authors declare that they have no competing interests.

References

1. O’Neill J, editor. Tackling a global health crisis: initial steps. The Review on Antimicrobial Resistance. London: Wellcome Trust; 2015. Available from: https://amr-review.org/sites/default/files/Report-52.15.pdf.

2. WHO. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization; 2015a.

3. Founou LL, Founou RC, Essack SY. Antibiotic resistance in the food chain: a developing country-perspective. Front Microbiol. 2016;7:1881. doi:10.3389/fmicb.2016.01881

4. Labi A-K, Obeng-Nkrumah N, Nartey ET, et al. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey. Antimicrob Resist Infect Control. 2018;7(1):15. doi:10.1186/s13756-018-0299-z

5. Thu TA, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung NV. Antibiotic use in Vietnamese hospitals: a multicenter point-prevalence study. Am J Infect Control. 2012;40(9):840–844. doi:10.1016/j.ajic.2011.10.020

6. Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10(3):167–175. doi:10.1016/S1473-3099(10)70027-X

7. Heritage J, Elliott MN, Stivers T, Richardson A, Mangione-Smith R. Reducing inappropriate antibiotics prescribing: the role of online commentary on physical examination findings. Patient Educ Couns. 2010;81(1):119–125. doi:10.1016/j.pec.2009.12.005

8. Gulen TA, Guner R, Celikbilek N, Keske S, Tasyaran M. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant Acinetobacter baumannii. Int J Infect Dis. 2015;38:32–35. doi:10.1016/j.ijid.2015.06.014

9. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346(mar11 3):f1493. doi:10.1136/bmj.f1493

10. Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 2010;1:134. doi:10.3389/fmicb.2010.00134

11. Founou RC, Founou LL, Essack SY, Butaye P. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One. 2017;12(12):e0189621. doi:10.1371/journal.pone.0189621

12. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-9

13. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27(2):128. doi:10.3904/kjim.2012.27.2.128

14. Gould I. Antibiotic resistance: the perfect storm. Int J Antimicrob Agents. 2009;34:S2–S5. doi:10.1016/S0924-8579(09)70549-7

15. Van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother. 2012;67(9):2090–2100. doi:10.1093/jac/dks214

16. Nicholson A, Tennant I, White L, et al. The knowledge, attitudes and practices of doctors regarding antibiotic resistance at a tertiary care institution in the Caribbean. Antimicrob Resist Infect Control. 2018;7(1):23. doi:10.1186/s13756-018-0315-3

17. Gebrekirstos NH, Workneh BD, Gebregiorgis YS, et al. Non-prescribed antimicrobial use and associated factors among customers in drug retail outlet in Central Zone of Tigray, northern Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control. 2017;6(1):70. doi:10.1186/s13756-017-0227-7

18. Sileshi A, Tenna A, Feyissa M, Shibeshi W. Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study. BMC Pharmacol Toxicol. 2016;17(1):7. doi:10.1186/s40360-016-0057-x

19. Holloway K, Green T, World Health Organization. Drug and Therapeutics Committees: A Practical Guide. 2003.

20. Quick JD, Hogerzeil HV, Rankin JR, et al, editors‎. Managing drug supply: the selection, procurement, distribution, and use of pharmaceuticals/Management Sciences for Health in collaboration with the World Health Organization. 2nd edition, rev. and expanded. West Hartford: Kumarian Press; 1997.

21. Phillips M, Gayman J, Todd M. ASHP guidelines on medication-use evaluation. American society of health-system pharmacists. Am J Health Syst Pharm. 1996;53(16):1953–1955.

22. Ahiabu M-A, Tersbol BP, Biritwum R, Bygbjerg IC, Magnussen PA. Retrospective audit of antibiotic prescriptions in primary health-care facilities in eastern region, Ghana. Health Policy Plan. 2015;31(2):250–258. doi:10.1093/heapol/czv048

23. Newman MJ. Nosocomial and community acquired infections in Korle Bu Teaching Hospital, Accra. West Afr J Med. 2009;28(5):300–303. doi:10.4314/wajm.v28i5.55005

24. Magill SS, Edwards JR, Beldavs ZG. Prevalence of antimicrobial use in USA acute care hospitals. JAMA. 2014;312(14):1438–1446. doi:10.1001/jama.2014.12923

25. Ahoyo T, Bankolé H, Adéoti F, Gbohoun A, Assavèdo S, Amoussou-Guénou M. Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012. Antimicrob Resist Infect Control. 2014;3(1):17. doi:10.1186/2047-2994-3-17

26. Ansari F, Erntell M, Goossens H, Davey P, Ii E, Care H. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–1504. doi:10.1086/644617

27. ECDC. Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals. Stockholm: European Centre for Disease Prevention; 2013.

28. Gube AA, Gonfa R, Tadesse T. Evaluation of antibiotic use in medical ward of Fitche District Hospital North Showa Zone Oromia Region Ethiopia. Adv Pharmacoepidemiol Drug Saf. 2017;6(3).

29. Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15:12–15. doi:10.1111/j.1469-0691.2009.02725.x

30. Clean Care is Safer Care Team. Report on the Burden of Endemic Health-Care Associated Infection Worldwide. Geneva: World Health Organisation; 2011. Available from: https://apps.who.int/iris/bitstream/handle/10665/80135/9789241501507_eng.pdf?sequence=1

31. Ceyhan M1, Yildirim I, Ecevit C, et al. Inappropriate Antimicrobial Use in Turkish Pediatric Hospitals: A Multicenter Point Prevalence Survey. Int J Infect Dis. 2010;14(1):e55–61.

32. Saleem Z, Saeed H, Hassali MA, et al. Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications. Antimicrob Resist Infect Control. 2019;8(1):188. doi:10.1186/s13756-019-0649-5

33. Chowdhury AA, Roy T, Faroque A, Bachar SC, Asaduzzaman M, Nasrin N. A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh. BMC Public Health. 2011;11(1):779. doi:10.1186/1471-2458-11-779

34. Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary Care Hospital in Greece. Infect Control Hosp Epidemiol. 2008;29(7):615–622. doi:10.1086/589333

35. Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst. 2014. doi:10.1002/14651858.CD007482.pub3

36. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM. Effect of antibiotic therapy on the density of Vancomycin-resistant Enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925–1932. doi:10.1056/NEJM200012283432604

37. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20(5):1126–1133. doi:10.1093/clinids/20.5.1126

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]